Article

Jeffrey Whitman, MD, receives Doctors of Distinction Award

Dallas-Dr Jeffrey Whitman, president and chief surgeon of the Key-Whitman Eye Center, and president of the American College of Eye Surgeons, will be presented with the Doctors of Distinction Award at the Dallas Chapter of Hadassah's third annual gala.

Dallas-Dr Jeffrey Whitman, president and chief surgeon of the Key-Whitman Eye Center, and president of the American College of Eye Surgeons, will be presented with the Doctors of Distinction Award at the Dallas Chapter of Hadassah's third annual gala.

The award is for a local doctor or group of doctors who are dedicated to the community as well as to their profession.

"Dr. Whitman is committed to advancing the field of eye surgery, becoming one of the few physicians in North Texas to be board-certified in LASIK. In addition he and his wife have traveled to Israel several times to see for themselves the incredible medical advances being made there in the field of ophthalmology," says Robin Teig, director of the Dallas Chapter of Hadassah.

The gala will take place at the Westin Park Central, 12720 Merit Drive in Dallas, at 6 p.m., Sunday, Oct. 28. Tickets are $180 per person and advertising and sponsorship opportunities are available. Advance reservations are required. For information, please contact Shirley Frankl at the Dallas Chapter of Hadassah at 214/691-1948 or chapter.dallas@hadassah.org. Funds raised from this event will go to the Hadassah Medical Organization.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.